boostAGErx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: cost-sensitive shoppers prepaying 12 months for low-cost GLP-1
Price is where boostAGErx scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as sermorelin. Care is 100% online with licensed providers, free shipping and clinical evaluation included, and the membership fee is refunded if you're not approved. Operated by Med Excellence United LLC, a Delaware company.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to boostAGErx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
boostAGErx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $95/mo (12-month plan rate)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored boostAGErx
Each dimension is scored algorithmically from boostAGErx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.6/10At $95/mo (12-month plan rate), boostAGErx runs about 49% below the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.6/10boostAGErx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.3/10Online intake and platform experience (app/portal-based, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.6/10boostAGErx's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
5.4/10boostAGErx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this boostAGErx review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $95–$145/mo across 2 dose/plan tiers (checked August 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with boostAGErx
We walked boostAGErx’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a short (~5-minute) online health assessment to check eligibility.
- 2Receive member-portal credentials and answer the fuller health intake quiz.
- 3A licensed clinician in your state reviews your info and, if appropriate, prescribes a personalized GLP-1 plan (prescription not guaranteed).
- 4Compounded medication is prepared by Manifest Pharmacy and shipped in temperature-appropriate packaging.
- Homepage FAQ shows pricing before intake: Semaglutide from $95/mo, Tirzepatide from $145/mo; price stated to include physician review, personalized plan, an Online Clinician Visit, and the medication.
- Cash-only, no insurance accepted/required; accepts major credit cards; states the medication price will not increase.
- Full refund if the medical team determines you don't qualify; 14-day right to withdraw, but shipped compounded medications cannot be returned; refunds in 7-10 business days if approved before shipping.
- Compounded medication disclosed as not FDA-approved; free shipping advertised.
- Also markets hormone/peptide therapies (e.g., Sermorelin) alongside GLP-1 weight loss.
GLP-1 medications boostAGErx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
GLP-1 'starting at $95/mo' on 12-month plan paid upfront; actual price varies by product/plan
GLP-1 'starting at $95/mo' (12-month upfront); actual price varies by product/plan
Ready to get started?
Plans and promotions change often, so check boostAGErx's current pricing and active discounts before you decide.
What we like
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
- Also offers peptide therapy such as sermorelin
- 100% online with licensed providers (no clinic visit)
Watch-outs
- Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
- Compounded medications are non-refundable once dispensed
- Pharmacy partner not named on the site
- Not LegitScript-certified (no certification displayed)
- States of operation not published
Is boostAGErx worth it?
boostAGErx is aimed squarely at cost-sensitive shoppers prepaying 12 months for low-cost GLP-1. It runs $95/month (12-month plan rate); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. No single feature of its GLP-1 program sets it apart from the category on its own, so the price and terms below are the things to compare.
Worth knowing before you sign up: boostAGErx runs entirely online and refunds you if it doesn't work out.
How much boostAGErx costs
Compounded semaglutide runs $95/month (12-month plan rate) and compounded tirzepatide runs $145/month (starting dose).
Because boostAGErx's headline figure is a 12-month plan rate, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare boostAGErx with the month-to-month prices of the alternatives below instead.
Eden (about $99/month) is one of the closest alternatives to weigh boostAGErx against.
Medications: what boostAGErx prescribes
boostAGErx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Who boostAGErx is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
boostAGErx is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Price is where boostAGErx scores best in our breakdown.
Ready to start with boostAGErx?
From $95/mo (12-month plan rate). See current pricing and start your free consultation.
boostAGErx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare boostAGErx vs…
boostAGErx scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
boostAGErx vs Amazon One Medical
Amazon One Medical scores 8.5/10
boostAGErx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this boostAGErx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See boostAGErx's current pricing
Plans from $95/mo (12-month plan rate). Start your free consultation to check eligibility and today's price.